TSXV:BTI.H - Post by User
Comment by
jdstoxon Sep 24, 2018 3:11pm
143 Views
Post# 28679677
RE:RE:Deals, deals and more deals
RE:RE:Deals, deals and more dealsFair enough, regardless.
So far, xB3 has shown itself to be a top level candidate, if not the top level candidate, to be the key that gets drugs into the CNS.
Bioasis has embarked on the studies and other activities to prove that, one way or the other.
If that key, xB3, does only one thing, effectively and safely treats tumours in the brain in a manner similar to how they can be treated in the body, then that's one heeluva swell situation for shareholders to be in. Treating neuro diseases is a wide open unmet field that's worth tens of billions per year.
So if we've got the key, then it's got to be worth something, probably a lot.
I can't think of any other reason for shareholders to own this stock, or for the Bioasis team to come on board to prove that, other than that the potential value makes it all worth it.
I can't engage in public speculation, or give guidance to anybody. The company has stated that there will be no public discussion of BD deals unless and until they happen. But it seems to me and to most everybody else that whoever comes up with such a key to the brain should be a big winner. That's just following the general principles of business.
If you build it, they will come.
Almost silly to think that they wouldn't.
jdstox